Adherence to Anti-Osteoporotic Treatment and Clinical Implications after Hip Fracture: A Systematic Review.

anti-osteoporotic treatment hip fracture mortality re-fracture risk

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
24 Apr 2021
Historique:
received: 04 04 2021
revised: 18 04 2021
accepted: 22 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

The role of anti-osteoporotic treatment as part of the secondary prevention after hip fracture in terms of mortality and re-fracture risk has been studied, and the results are promising. Decreased treatment adherence and compliance is a problem that needs to be addressed by healthcare professionals. A systematic review of the literature was performed using the PubMed database with terms that included hip fracture, mortality, second fracture, and specific anti-osteoporotic treatment. We included 28 articles, 21 regarding mortality and 20 re-fracture rates in hip fracture patients. All studies showed lower mortality after hip fracture associated with anti-osteoporotic treatment, mostly bisphosphonate agents. The re-fracture risk is still debatable, since conflicting data were found. Although most of the studies showed notable effects on mortality and re-fracture rates associated with anti-osteoporotic treatment, we still need more data to validate the actual results.

Identifiants

pubmed: 33923261
pii: jpm11050341
doi: 10.3390/jpm11050341
pmc: PMC8146075
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

J Bone Miner Res. 2007 Aug;22(8):1147-54
pubmed: 17635040
Osteoporos Int. 2011 Jul;22(7):2099-106
pubmed: 21528360
Endocr Pract. 2018 Aug;24(8):718-725
pubmed: 30084682
J Am Med Dir Assoc. 2014 Oct;15(10):725-31
pubmed: 25017390
Osteoporos Int. 2011 Jul;22(7):2083-98
pubmed: 21607809
Osteoporos Int. 2013 May;24(5):1759-63
pubmed: 23296742
J Bone Miner Res. 2012 Mar;27(3):687-93
pubmed: 22095631
Osteoporos Int. 2004 Mar;15(3):175-9
pubmed: 14691617
PLoS One. 2018 Jun 1;13(6):e0198006
pubmed: 29856795
J Am Med Dir Assoc. 2017 Jun 1;18(6):515-521
pubmed: 28238673
J Bone Miner Res. 2018 Aug;33(8):1422-1434
pubmed: 29744914
Osteoporos Int. 2019 Oct;30(10):1973-1982
pubmed: 31367949
Endocr Pract. 2020 Mar;26(3):332-339
pubmed: 31859555
Arch Osteoporos. 2020 Jan 3;15(1):12
pubmed: 31897772
Bone. 2003 May;32(5):468-73
pubmed: 12753862
Osteoporos Int. 2017 Jul;28(7):2023-2034
pubmed: 28451733
Arch Gerontol Geriatr. 2020 May - Jun;88:104021
pubmed: 32058125
Osteoporos Int. 2011 Sep;22(9):2551-6
pubmed: 20959963
Reumatismo. 2012 Mar 16;64(1):18-26
pubmed: 22472779
Int J Cardiol. 2013 Jun 20;166(2):385-93
pubmed: 22112679
Osteoporos Int. 2017 Mar;28(3):775-780
pubmed: 28028554
Osteoporos Sarcopenia. 2016 Jun;2(2):77-81
pubmed: 30775470
Calcif Tissue Int. 2019 Dec;105(6):630-641
pubmed: 31531720
Osteoporos Int. 2017 Jan;28(1):169-178
pubmed: 27812809
Arch Osteoporos. 2019 Oct 18;14(1):100
pubmed: 31628566
Osteoporos Int. 2016 Jan;27(1):387-96
pubmed: 26576544
Osteoporos Int. 2013 Jan;24(1):245-52
pubmed: 22638712
Osteoporos Int. 2017 Dec;28(12):3289-3300
pubmed: 28770272
Osteoporos Int. 2018 Jul;29(7):1609-1616
pubmed: 29704026
Osteoporos Int. 2020 Aug;31(8):1555-1563
pubmed: 32221674
J Am Geriatr Soc. 2011 Nov;59(11):2084-90
pubmed: 22091563
BMJ Open. 2017 Jul 12;7(7):e014795
pubmed: 28706089
Osteoporos Int. 2020 Jan;31(1):77-84
pubmed: 31511912
J Am Med Dir Assoc. 2020 Jun;21(6):811-816
pubmed: 31839557
Clin Exp Immunol. 2006 Dec;146(3):371-80
pubmed: 17100755
J Bone Miner Res. 2006 Apr;21(4):549-55
pubmed: 16598375
Injury. 2008 Oct;39(10):1157-63
pubmed: 18653186
Orthop Surg. 2019 Oct;11(5):777-783
pubmed: 31429532
J Bone Miner Res. 2014 Sep;29(9):1926-8
pubmed: 24956507
Pak J Med Sci. 2016 Mar-Apr;32(2):499-504
pubmed: 27182270
Cancer Immunol Immunother. 2009 Jan;58(1):31-8
pubmed: 18458903
Osteoporos Int. 2013 Aug;24(8):2135-52
pubmed: 23589162
JAMA Intern Med. 2019 Nov 1;179(11):1491-1500
pubmed: 31424486
Osteoporos Int. 2013 Nov;24(11):2887-92
pubmed: 23681088
Osteoporos Int. 2010 Jan;21(1):71-9
pubmed: 19499274
Osteoporos Int. 2015 Oct;26(10):2479-89
pubmed: 26018090
Osteoporos Int. 2005 Dec;16(12):1583-90
pubmed: 16217590
J Clin Endocrinol Metab. 2011 Apr;96(4):1006-14
pubmed: 21289270
J Am Geriatr Soc. 2010 Apr;58(4):650-7
pubmed: 20398147
Climacteric. 2015;18(6):805-12
pubmed: 26029985
Osteoporos Int. 2018 Aug;29(8):1747-1757
pubmed: 29947869
Ann Intern Med. 2010 Mar 16;152(6):380-90
pubmed: 20231569
Osteoporos Int. 2012 Feb;23(2):695-703
pubmed: 21394496
Osteoporos Int. 2014 Jan;25(1):77-83
pubmed: 23812596
Arch Osteoporos. 2017 Dec;12(1):58
pubmed: 28643265
J Bone Miner Res. 2020 Sep;35(9):1676-1684
pubmed: 32488902
Ann N Y Acad Sci. 2012 Aug;1263:29-40
pubmed: 22831177
Osteoporos Int. 2003 Sep;14(9):722-7
pubmed: 12904833
J Bone Joint Surg Br. 2012 Jan;94(1):102-6
pubmed: 22219256
Calcif Tissue Int. 2021 Mar 12;:
pubmed: 33712919
N Engl J Med. 2007 Nov 1;357(18):1799-809
pubmed: 17878149
Biomed Res Int. 2020 Aug 20;2020:5914502
pubmed: 32904518
Orthop Surg. 2019 Jun;11(3):380-385
pubmed: 31058448

Auteurs

Ramona Dobre (R)

"Carol Davila", University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Endocrinology, National Institute of Endocrinology CI Parhon, 011853 Bucharest, Romania.

Dan Alexandru Niculescu (DA)

"Carol Davila", University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Endocrinology, National Institute of Endocrinology CI Parhon, 011853 Bucharest, Romania.

Răzvan-Cosmin Petca (RC)

"Carol Davila", University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Urology, "Prof. Dr. Th. Burghele" Clinical Hospital, 050659 Bucharest, Romania.

Răzvan-Ionuț Popescu (RI)

"Carol Davila", University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Urology, "Prof. Dr. Th. Burghele" Clinical Hospital, 050659 Bucharest, Romania.

Aida Petca (A)

"Carol Davila", University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Obstetrics and Gynecology, Elias University Hospital, 011461 Bucharest, Romania.

Cătălina Poiană (C)

"Carol Davila", University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Endocrinology, National Institute of Endocrinology CI Parhon, 011853 Bucharest, Romania.

Classifications MeSH